Malignant Large Intestinal Neoplasm — Research

Malignant Large Intestinal Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	486	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	7	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	1	`("Malignant Large Intestinal Neoplasm"[tiab] OR "Large Intestinal Cancer"[tiab] OR "Cancer of Large Intestine"[tiab] OR "Cancer of the Large Intestine"[tiab]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (370)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 370 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.
· Lancet Oncol · 2011 · PMID 21163703 · validated civic_curation pubmed
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy.
· Br J Cancer · 2010 · PMID 20628391 · validated civic_curation pubmed
Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
· BMC Cancer · 2013 · PMID 23374602 · validated civic_curation pubmed
Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.